Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function

Parasite Immunology

Volumn 35, Issue 3-4, 2013, Pages 109-119

  Wanderley, J L M ^a,b   Thorpe, P E ^c   Barcinski, M A ^d,e   Soong, L ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Dendritic cell; Immune evasion; Leishmania spp; Leishmaniasis

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE;

AMASTIGOTE; ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE EVASION; IMMUNE TOLERANCE; LEISHMANIA MEXICANA; MICE; PHOSPHATIDYLSERINES;

EID: 84873472660     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12019     Document Type: Article

References (62)

1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B & Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7: 581-596.
2. Ji J, Sun J & Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 2003; 71: 4278-4288.
3. Vargas-Inchaustegui DA, Xin L & Soong L. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses. J Immunol 2008; 180: 7537-7545.
4. Jones DE, Buxbaum LU & Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol 2000; 165: 364-372.
5. Buxbaum LU, Uzonna JE, Goldschmidt MH & Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol 2002; 32: 3206-3215.
6. Ji J, Sun J, Qi H & Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 2002; 66: 338-345.
7. Ramer AE, Vanloubbeeck YF & Jones DE. Antigen-responsive CD4 + T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype. Infect Immun 2006; 74: 1547-1554.
8. Xin L, Wanderley JL, Wang Y, Vargas-Inchaustegui DA & Soong L. The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice. Parasite Immunol 2011; 33: 170-180.
9. Antoine JC, Jouanne C, Lang T, Prina E, de Chastellier C & Frehel C. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun 1991; 59: 764-775.
10. Antoine JC, Lang T, Prina E, Courret N & Hellio R. H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana. J Cell Sci 1999; 15: 2559-2570.
11. Prina E, Jouanne C, de Souza Lao S, Szabo A, Guillet JG & Antoine JC. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol 1993; 151: 2050-2061.
12. Cameron P, McGachy A, Anderson M, et al. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol 2004; 173: 3297-3304.
13. Ruhland A & Kima PE. Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol 2009; 122: 28-36.
14. Prina E, Abdi SZ, Lebastard M, Perret E, Winter N & Antoine JC. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 2004; 117: 315-325.
15. Xin L, Li K & Soong L. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol Immunol 2008; 45: 3371-3382.
16. de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C & Barcinski MA. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol 2001; 11: 1870-1873.
17. Wanderley JL, Moreira ME, Benjamin A, Bonomo AC & Barcinski MA. Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. J Immunol 2006; 176: 1834-1839.
18. Fischer K, Voelkl S, Berger J, Andreesen R, Pomorski T & Mackensen A. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8 + T cells. Blood 2006; 108: 4094-4101.
19. Smrz D, Draberova L & Draber P. Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins. J Biol Chem 2007; 282: 10487-10497.
20. Jeong J & Conboy IM. Phosphatidylserine directly and positively regulates fusion of myoblasts into myotubes. Biochem Biophys Res Commun 2011; 414: 9-13.
21. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL & Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
22. Damatta RA, Seabra SH, Deolindo P, Arnholdt AC, Manhães L, Goldenberg S & de Souza W. Trypanosoma cruzi exposes phosphatidylserine as an evasion mechanism. FEMS Microbiol Lett 2007; 266: 29-33.
23. Seabra SH, de Souza W & Damatta RA. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion. Biochem Biophys Res Commun 2004; 324: 744-752.
24. Soares MM, King SW & Thorpe PE. Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med 2008; 14: 1357-1362.
25. Laliberte JP & Moss B. Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc Natl Acad Sci USA 2009; 106: 17517-17521.
26. Mercer J & Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008; 320: 531-535.
27. Mercer J & Helenius A. Apoptotic mimicry: phosphatidylserine-mediated macropinocytosis of vaccinia virus. Ann N Y Acad Sci 2010; 1209: 49-55.
28. He J, Yin Y, Luster TA, Watkins L & Thorpe PE. Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res 2009; 15: 6871-6880.
29. Domanski PJ, Patel PR, Bayer AS, et al. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus. Infect Immun 2005; 73: 5229-5232.
30. Saraiva EM, Pimenta PF, Pereira ME & de Souza W. Isolation and purification of amastigotes of Leishmania mexicana amazonensis by a gradient of Metrizamide. J Parasitol 1983; 69: 627-629.
31. Lasakosvitsch F, Gentil LG, dos Santos MR, da Silveira JF & Barbieri CL. Cloning and characterisation of a cysteine proteinase gene expressed in amastigotes of Leishmania (L.) amazonensis. Int J Parasitol 2003; 33: 445-454.
32. Xin L, Vargas-Inchaustegui DA, Raimer SS, et al. Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J Immunol 2010; 184: 7047-7056.
33. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004; 4: 223-231.
34. Albacker LA, Karisola P, Chang YJ, et al. TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. J Immunol 2010; 185: 6839-6849.
35. Xia CQ, Campbell KA & Clare-Salzler MJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr Opin Organ Transplant 2009; 14: 338-343.
36. Gurung P, Kucaba TA, Ferguson TA & Griffith TS. Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. J Immunol 2009; 183: 6114-6123.
37. Marin-Gallen S, Clemente-Casares X, Planas R, et al. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clin Exp Immunol 2010; 160: 207-214.
38. Hoffmann PR, Kench JA, Vondracek A, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 2005; 174: 1393-1404.
39. Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P & Koprowski H. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci USA 1988; 85: 4852-4856.
40. Moody MA, Liao HX, Alam SM, et al. Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines. J Exp Med 2010; 207: 763-776.
41. Lodge R, Ouellet M, Barat C, Andreani G, Kumar P & Tremblay MJ. HIV-1 promotes intake of Leishmania parasites by enhancing phosphatidylserine-mediated, CD91/LRP-1-dependent phagocytosis in human macrophages. PLoS ONE 2012; 7: e32761.
42. Gonzáles U, Pinart M, Reveiz L, Rengifo-Pardo M, Tweed J, Macaya A & Alvar J. Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. Clin Infect Dis 2010; 51: 409-419.
43. Fadok VA, McDonald PP, Bratton DL & Henson PM. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans 1998; 26: 653-656.
44. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP & Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281: 38376-38384.
45. Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, et al. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J Immunol 2010; 185: 4030-4041.
46. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY & Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
47. Wanderley JL, Pinto da Silva LH, Deolindo P, et al. Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS ONE 2009; 4: e5733.
48. Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012; 119: 5640-5649.
49. Chen X, Doffek K, Sugg SL & Shilyansky J. Phosphatidylserine regulates the maturation of human dendritic cells. J Immunol 2004; 173: 2985-2994.
50. Blander JM & Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440: 808-812.
51. Blachere NE, Darnell RB & Albert ML. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 2005; 3: e185.
52. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S & Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423-434.
53. Albert ML, Sauter B & Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
54. O'Garra A & Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007; 7: 425-428.
55. Soong L. Modulation of dendritic cell function by Leishmania parasites. J Immunol 2008; 180: 4355-4360.
56. Sacks D & Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2: 845-858.
57. Guy RA & Belosevic M. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect Immun 1993; 61: 1553-1558.
58. Hoffmann PR, deCathelineau AM, Ogden CA, et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 2001; 155: 649-659.
59. Velez ID, Gilchrist K, Arbelaez MP, et al. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Trans R Soc Trop Med Hyg 2005; 99: 593-598.
60. Montalvo-Alvarez AM, Folgueira C, Carrion J, Monzote-Fidalgo L, Canavate C & Requena JM. The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection. J Biomed Biotechnol 2008; 2008: 695432.
61. Campbell K, Diao H, Ji J & Soong L. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis. Infect Immun 2003; 71: 6270-6278.
62. Weingärtner A, Drobot B, Herrmann A, Sanchez-Cañete MP, Gamarro F, Castanys S & Günther-Pomorsky T. Disruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasion. PLoS ONE 2010; 5: e12443.